#fop

1 story

#atebrioz #fda approval #fibrodysplasia ossificans progressiva #health #medicine #rare genetic disease #zilurgisertib

FDA approves Atebrioz for rare bone growth disorder
The FDA has approved Atebrioz to treat fibrodysplasia ossificans progressiva, a rare genetic disease where soft tissue gradually turns to bone.
WebMD · 1m